A Phase 1 interventional study of PN400 in Healthy, sponsored by POZEN. Completed. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-04-30.
Sponsored by POZEN (part of Aralez Pharmaceuticals) · Phase 1, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Pharmacokinetic study in healthy subjects with single and repeat b.i.d. dosing of PN 400 tablets from the same drug product batch.
POZEN is the lead sponsor of 27 studies on the registry; none are open to participants now.
First submitted before POZEN became part of Aralez Pharmaceuticals.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Healthy male or non-pregnant female subjects between 18-55 years of age as well as other standard inclusion criteria for a study of this nature
Exclusion Criteria:
Standard inclusion criteria for a study of this nature
Drug pages: NaproxenStudies of NaproxenNaproxen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · EsomeprazoleStudies of EsomeprazoleEsomeprazole pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
500 mg esomeprazole/20 mg naproxen, once daily on Days 1-10 and twice daily on Days 2-9
Pharmacokinetic profile following dosing with PN400
Time frame: 24-hour PK on Day 1 & Day 10 of each treatment period
To evaluate the safety of PN400
Time frame: Day 1-10 of each treatment period
No study locations are listed for this record.
The record gives a start of Jan 2008, a primary completion of Feb 2008 and a completion of Feb 2008. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Naproxen · Esomeprazole